588 related articles for article (PubMed ID: 23953240)
21. Galectin-1: a small protein with major functions.
Camby I; Le Mercier M; Lefranc F; Kiss R
Glycobiology; 2006 Nov; 16(11):137R-157R. PubMed ID: 16840800
[TBL] [Abstract][Full Text] [Related]
22. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase.
Sun ZJ; Chen G; Zhang W; Hu X; Huang CF; Wang YF; Jia J; Zhao YF
J Pharmacol Exp Ther; 2010 Aug; 334(2):500-12. PubMed ID: 20484154
[TBL] [Abstract][Full Text] [Related]
23. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer.
Sutendra G; Dromparis P; Kinnaird A; Stenson TH; Haromy A; Parker JM; McMurtry MS; Michelakis ED
Oncogene; 2013 Mar; 32(13):1638-50. PubMed ID: 22614004
[TBL] [Abstract][Full Text] [Related]
25. [The vascular endothelial growth factor (VEGF): a model of gene regulation and a marker of tumour aggressiveness. An obvious therapeutic target?].
Grépin R; Pagès G
J Soc Biol; 2009; 203(2):181-92. PubMed ID: 19527632
[TBL] [Abstract][Full Text] [Related]
26. The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy.
van der Meel R; Symons MH; Kudernatsch R; Kok RJ; Schiffelers RM; Storm G; Gallagher WM; Byrne AT
Drug Discov Today; 2011 Mar; 16(5-6):219-28. PubMed ID: 21262381
[TBL] [Abstract][Full Text] [Related]
27. A key role for galectin-1 in sprouting angiogenesis revealed by novel rationally designed antibodies.
van Beijnum JR; Thijssen VL; Läppchen T; Wong TJ; Verel I; Engbersen M; Schulkens IA; Rossin R; Grüll H; Griffioen AW; Nowak-Sliwinska P
Int J Cancer; 2016 Aug; 139(4):824-35. PubMed ID: 27062254
[TBL] [Abstract][Full Text] [Related]
28. Involvement of matrix metalloproteinases in the inhibition of cell invasion and migration through the inhibition of NF-[kappa]B by the new synthesized ethyl 2-[N-p-chlorobenzyl-(2'-methyl)]anilino-4-oxo-4,5-dihydrofuran-3-carboxylate (JOTO1007) in human cervical cancer Ca ski cells.
Huang AC; Hsu SC; Kuo CL; Liao CL; Lai KC; Lin TP; Wu SH; Lu HF; Tang NY; Yang JS; Chung JG
In Vivo; 2009; 23(4):613-9. PubMed ID: 19567397
[TBL] [Abstract][Full Text] [Related]
29. Role of Galectins in Tumors and in Clinical Immunotherapy.
Chou FC; Chen HY; Kuo CC; Sytwu HK
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
[TBL] [Abstract][Full Text] [Related]
30. Aloe emodin inhibits colon cancer cell migration/angiogenesis by downregulating MMP-2/9, RhoB and VEGF via reduced DNA binding activity of NF-κB.
Suboj P; Babykutty S; Valiyaparambil Gopi DR; Nair RS; Srinivas P; Gopala S
Eur J Pharm Sci; 2012 Apr; 45(5):581-91. PubMed ID: 22227305
[TBL] [Abstract][Full Text] [Related]
31. Tissue plasminogen activator induces microglial inflammation via a noncatalytic molecular mechanism involving activation of mitogen-activated protein kinases and Akt signaling pathways and AnnexinA2 and Galectin-1 receptors.
Pineda D; Ampurdanés C; Medina MG; Serratosa J; Tusell JM; Saura J; Planas AM; Navarro P
Glia; 2012 Apr; 60(4):526-40. PubMed ID: 22162045
[TBL] [Abstract][Full Text] [Related]
32. Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway.
Tsubaki M; Satou T; Itoh T; Imano M; Ogaki M; Yanae M; Nishida S
Toxicol Appl Pharmacol; 2012 Mar; 259(3):402-10. PubMed ID: 22326785
[TBL] [Abstract][Full Text] [Related]
33. Maslinic acid inhibits the metastatic capacity of DU145 human prostate cancer cells: possible mediation via hypoxia-inducible factor-1α signalling.
Park SY; Nho CW; Kwon DY; Kang YH; Lee KW; Park JH
Br J Nutr; 2013 Jan; 109(2):210-22. PubMed ID: 22716951
[TBL] [Abstract][Full Text] [Related]
34. Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression.
Bacigalupo ML; Carabias P; Troncoso MF
World J Gastroenterol; 2017 Aug; 23(29):5266-5281. PubMed ID: 28839427
[TBL] [Abstract][Full Text] [Related]
35. Family of peptides synthesized in the human body have anticancer effects.
Vesely DL
Anticancer Res; 2014 Apr; 34(4):1459-66. PubMed ID: 24692673
[TBL] [Abstract][Full Text] [Related]
36. β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy.
Tang J; Li Z; Lu L; Cho CH
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):533-42. PubMed ID: 24012659
[TBL] [Abstract][Full Text] [Related]
37. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
38. The Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1.
Cousin JM; Cloninger MJ
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649167
[TBL] [Abstract][Full Text] [Related]
39. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
Li D; Williams JI; Pietras RJ
Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639
[TBL] [Abstract][Full Text] [Related]
40. Adaptation and learning of molecular networks as a description of cancer development at the systems-level: potential use in anti-cancer therapies.
Gyurkó DM; Veres DV; Módos D; Lenti K; Korcsmáros T; Csermely P
Semin Cancer Biol; 2013 Aug; 23(4):262-9. PubMed ID: 23796463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
